High-flow nasal oxygen is the reference treatment in acute hypoxemic respiratory failure: Con

Over the past decade and boosted by the coronavirus disease 2019 (COVID-19) pandemic, high-flow nasal oxygen (HFNO) has been increasingly used in the intensive care unit (ICU) to treat acute hypoxemic respiratory failure (AHRF). In this review, we show that despite this wide and rapid increase in th...

詳細記述

書誌詳細

主要な著者:	Gabriel Kemoun, Alexandre Demoule
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2025-07-01
シリーズ:	Journal of Intensive Medicine
主題:	Acute respiratory failure Intubation Low-income country High flow nasal cannula Patient self-inflicted lung injury Carbon emissions
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2667100X24001415
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!